Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
115 participants
INTERVENTIONAL
2014-06-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COMMunication and Education for the New CPAP Experience
NCT01377584
Long Term Efficacy of Education Programme on Continuous Positive Airway Pressure Treatment
NCT01428921
Effects of an Individualized Training Program on Severity Markers of Obstructives Sleep Apnea/Hypopnea Syndrome (OSAS)
NCT01256307
Effects of Telemedical Support on Therapeutic Results of CPAP Patients
NCT05440279
The Effects of Frequent Follow up on Compliance in Patients Receiving PAP Therapy Due to OSA (Pap: Positive Airway Pressure, OSA: Obstructive Sleep Apnea )
NCT05894733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
METHOD:
This single-center, randomized, controlled study was conducted at the Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital in Istanbul between June 2014 and April 2015. Eligible OSA patients were randomized to Standard Support (SS) group (general information about OSA and PAP treatment at baseline), or to Educational Support (ES) group (additional polysomnography chart viewing from both diagnostic and titration nights). All patients were scheduled to five PAP control visits between 2 weeks and 6 months after the PAP prescription. Primary outcome was the PAP compliance (4 h/night for 70% of all the nights) at the last visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Device and Standard Care
Positive Airway Pressure Device and Standard Support
Standard Support
General information about OSA and PAP treatment at baseline
Device and Educational Care
Positive Airway Pressure Device and Educational Support
Educational Support
General information about OSA and PAP treatment at baseline and additional polysomnography chart viewing from both diagnostic and titration nights
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Support
General information about OSA and PAP treatment at baseline and additional polysomnography chart viewing from both diagnostic and titration nights
Standard Support
General information about OSA and PAP treatment at baseline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be able to give informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sema Sarac, MD
Role: STUDY_CHAIR
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
89513307/1009/309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.